These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 16699475)

  • 1. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: bone disease in inflammatory bowel disease.
    Schulte CM
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():43-9. PubMed ID: 15352893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of osteoporosis in inflammatory bowel disease.
    Reinshagen M; Von Tirpitz C
    Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced osteoporosis in inflammatory bowel disease.
    Lidofsky S; Smith J
    Med Health R I; 2009 Apr; 92(4):128-30. PubMed ID: 19452756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.
    Valentine JF; Sninsky CA
    Am J Gastroenterol; 1999 Apr; 94(4):878-83. PubMed ID: 10201450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis associated with inflammatory bowel diseases].
    Miheller P; Tóth M; Pregun I; Tulassay Z
    Orv Hetil; 2004 May; 145(20):1045-51. PubMed ID: 15202326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2008 panorama on osteoporosis and inflammatory bowel disease.
    Sapone N; Pellicano R; Simondi D; Sguazzini C; Reggiani S; Terzi E; Rizzetto M; Astegiano M
    Minerva Med; 2008 Feb; 99(1):65-71. PubMed ID: 18299697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
    Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
    Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG; Gehlbach SH; Curtis JR; Youket TE; Worley K; Lange JL
    J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bone loss in inflammatory bowel disease.
    Lichtenstein GR
    Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis: strategies for prevention and management.
    Keen R
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
    Henderson S; Hoffman N; Prince R
    Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, prevention, and treatment of osteoporosis in men.
    Epperly TD; Moore KE
    J Gend Specif Med; 2002; 5(6):33-8. PubMed ID: 12503224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.